SHP.L
Shire plc
LSE
People also watch:SN.LWPP.LSDR.LSMIN.LREL.L
4,914.0019.00 (0.39%)
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close4,895.00
Open4,875.00
Bid4,830.00 x 7500
Ask4,950.00 x 21100
52wk Range2,707.19 - 5,870.00
Day's Range4,838.00 - 4,918.00
Volume1,119,664
Avg Vol (3m)2,931,223
As of 12:13 PM EDT. Market closed.
  • Market Realist2 days ago

    How Analysts Think Investors Should Play Vertex Pharmaceuticals

    Vertex Pharmaceuticals (VRTX) will report its 2Q16 earnings on July 27, 2016. Based in Boston, VRTX is a global biotechnology company that primarily focuses on cystic fibrosis drugs.

  • Barrons.com3 days ago

    Valeant & Endo: Imagining a World With No Drug Pricing Controversies

    Stocks like Valeant Pharmaceuticals International (VRX), Mallinckrodt (MNK), Endo International (ENDP), and Allergan (AGN) have been hit hard this year by concerns about how their drugs are priced. Guggenheim analyst Louise Chen and team, however, argue that the drug-pricing overhang could be on its way out. The Medicare Part B Demo received 1,300 comments demonstrating how controversial any changes to drug pricing could be...In our coverage universe, the high priced drug debate has weighed on Allergan, Shire (SHPG), Valeant Pharmaceuticals International, Endo International, Mallinckrodt and Jazz Pharmaceuticals (JAZZ).